Stocks of Astera Labs Inc (NASDAQ:ALAB) traded higher last session on Wall Street, down -1.06% to $115.27.
ALAB stock price is now 47.97% away from the 50-day moving average and 79.27% away from the 200-day moving average. The market capitalization of the company currently stands at $18.28B.
With the price target of $120, Citigroup recently initiated with Buy rating for Astera Labs Inc (NASDAQ: ALAB). On September 04, 2024, Morgan Stanley Upgraded its previous ‘Equal-Weight’ rating to ‘Overweight’ on the stock keeping its target price maintained at $55, while ‘Evercore ISI’ rates the stock as ‘Outperform’
In other news, ALBA MANUEL, Director sold 63,000 shares of the company’s stock on Dec 03 ’24. The stock was sold for $7,108,446 at an average price of $112.83. Upon completion of the transaction, the Director now directly owns 459,863 shares in the company, valued at $53.01 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 02 ’24, Director ALBA MANUEL sold 63,000 shares of the business’s stock. A total of $6,485,419 was realized by selling the stock at an average price of $102.94. This leaves the insider owning 471,863 shares of the company worth $54.39 million. A total of 27.49% of the company’s stock is owned by insiders.
During the past 12 months, Astera Labs Inc has had a low of $36.22 and a high of $117.26. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 10.74, and a quick ratio of 10.46. The fifty day moving average price for ALAB is $76.6166 and a two-hundred day moving average price translates $64.01514 for the stock.
The latest earnings results from Astera Labs Inc (NASDAQ: ALAB) was released for 2024-09-30. The net profit margin was -30.69% and return on equity was -16.05% for ALAB. The company reported revenue of $113.09 million for the quarter, compared to $36.93 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 206.23 percent.
